Febuxostat Clinical Trials

4 actively recruiting trials

No change since May 2026

Also known as: Feburic, Usoric® Tab 40mg

Pipeline

Phase 1: 1Phase 3: 1Phase 4: 2

Top Sponsors

Seoul National University Hospital1
Saga University1
Innovent Biologics Technology Limited (Shanghai R&D Center)1
Fujita Health University1

Indications

Arthritis3
Gout2
Uric Acid1
Parkinson's Disease (PD)1
Parkinson's Disease1

Other4 trials

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

Phase 1

Effect of Dotinurad in Hyperuricemia With Hypertension

Phase 4

Tigulixostat (IBI128) vs Febuxostat in Gout

Phase 3

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.